Open AccessHypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn’s Disease Patients Undergoing Ileocolic Resection
Author(s) -
Ravi S. Shah,
Salam Bachour,
Jian Xue,
Stefan D. Holubar,
Tracy L. Hull,
Jean–Paul Achkar,
Jessica Philpott,
Taha Qazi,
Florian Rieder,
Benjamin Cohen,
Miguel Regueiro,
Amy L. Lightner,
Benjamin Click
Publication year - 2021
Publication title -
journal of crohn's and colitis
Language(s) - English
Resource type - Journals
eISSN - 1876-4479
pISSN - 1873-9946
DOI - 10.1093/ecco-jcc/jjaa268
Subject(s) - medicine , vedolizumab , crohn's disease , ustekinumab , surgery , complication , abdominal surgery , bowel resection , disease , infliximab
There are limited data on the postoperative outcomes in Crohn's disease patients exposed to preoperative ustekinumab or vedolizumab. We hypothesised that preoperative biologic use in Crohn's disease is not associated with postoperative complications after ileocolic resection.